Active Ingredient: Cross-linked Sodium Hyaluronate

Concentration: 20 mg/mL

Molecular Weight: 2.5 – 3.0 MDa

Endotoxin Level: < 0.05 EU/mg

pH Level: 6.8 – 7.5

Package Contents: 3 x 2.0mL pre-filled sterile

Data source: Independent Multi-Center Trial (Study ID: HA20-CRT-2023, n=124, 24-week evaluation).

Wrinkle Depth Reduction: 63.4% at week 8

Dermal Density Increase: 41.2% (ultrasound measurement)

Tissue Integration Depth: 400µm distribution

Hydration Retention: 89% baseline moisture retention at day 30

Biocompatibility Rate: 98.7% (zero severe granuloma incidence)

Advanced CPM Technology Matrix

Injection Protocol

1. Preparation: Cleanse target dermal area with medical-grade Chlorhexidine or equivalent antiseptic.

2. Instrumentation: Utilize a 32G or micro-for administration.

3. Depth & Dosage: Maintain intra-dermal depth of 4-5mm. Administer 0.05mL to 0.1mL per injection site.

4. Treatment Cycle: Recommended base protocol is 3 consecutive sessions spaced at precise 4-week intervals.

5. Post-Care: Apply immediate post-treatment cooling protocols. Avoid heat exposure for 48 hours.